Generic Injectables Market Size, Industry Share, Demand, Report 2023-2028

Global Generic Injectables Market Overview:

The latest report published by IMARC Group, titled “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,”offers a comprehensive analysis of the industry, which comprises insights on thegeneric injectables market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global generic injectables market size reached US$ 43.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 70.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.

Generic injectables are pharmaceutical products that are identical or bioequivalent to the original branded injectable products but are marketed under a different brand name after the patent for the original product expires. They are manufactured using the same active pharmaceutical ingredients as the original product and are typically sold at a lower price than the branded product. They are widely used to treat various medical conditions such as cancer, infectious diseases, and autoimmune disorders. They are used in hospitals, clinics, and other medical facilities and are administered through intravenous, intramuscular, or subcutaneous routes.

Global Generic Injectables Market Trends:

The global market is majorly driven by the increasing demand for affordable healthcare products and services. In line with this, the expiration of patents for many branded injectable products is significantly contributing to the market. Furthermore, the growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease is positively influencing the market. Apart from this, the expansion of the global pharmaceutical industry is creating a positive outlook for the market. Moreover, the escalating generic drug utilization and rapid technological advancements in manufacturing processes are catalyzing the market. Besides, the increasing demand for biosimilars is offering numerous opportunities for the market. Additionally, the trend toward personalized medicine is accelerating the development of new injectable treatments that can be customized to individual patient needs.

Global Generic Injectables Market 2023-2028 Analysis and Segmentation

Competitive Landscape with Key Players:

  • Hospira (Pfizer)
  • Fresenius Kabi
  • Hikma
  • Sandoz (Novartis)
  • Sagent
  • Sanofi
  • Baxter

This report provides a deep insight into the global generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global generic injectables industry in any manner.

Also, Read the Full Blog: List of the TopGeneric Pharmaceuticals Injectables CompaniesWorldwide

Breakup by Therapeutic Area:

On the basis of the therapeutic area, the market has been classified intooncology, anesthesia, anti-infectives, parental nutrition and cardiovascular.

Amongst these, the oncology segment holds the largest market share.

Breakup by Container:

Based on the container, the market has been categorized intovials, ampoules, premix, and prefilled syringes.

Breakup by Distribution Channel:

  • Hospitals
  • Retail Pharmacy

Breakup by Region:

Region-wise, North America holds the leading position in the market. Other major regions includeEurope, Asia, Middle East and Africa, and Latin America.

TOC for the Generic Injectables Market Research Report:

  • Preface
  • Scope and Methodology
  • Executive Summary
  • Introduction
  • Generic Injectables Market SWOT Analysis
  • Value Chain Analysis
  • Price Analysis
  • Competitive Landscape

Report Coverage:

Report FeaturesDetails
Base Year of the Analysis2022
Historical Period2017-2022
Forecast Period2023-2028
UnitsUS$ Billion
Segment CoverageTherapeutic Area, Container, Distribution Channel, Region
Region CoveredAsia, Europe, North America, Latin America, Middle East and Africa
Companies CoveredHospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter
Customization Scope10% Free Customization
Report Price and Purchase OptionSingle User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support10-12 Weeks
Delivery FormatPDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

1. What was the size of the global generic injectables market in 2022?

2. What is the expected growth rate of the global generic injectables market during 2023-2028?

3. What has been the impact of COVID-19 on the global generic injectables market?

4. What are the key factors driving the global generic injectables market?

5. What is the breakup of the global generic injectables market based on the therapeutic area?

6. What is the breakup of the global generic injectables market based on the distribution channel?

7. What are the key regions in the global generic injectables market?

8. Who are the key players/companies in the global generic injectables market?

Some of the major players in the global generic injectables market include Hospira, Inc. (Pfizer Inc.), Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sandoz (Novartis), Sagent M&C, LLC, Sanofi S.A., Baxter International, Inc., etc.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

1 Preface
2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction

4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Region
5.4 Market Forecast
5.5 Major Players
6 Global Generic Drug Delivery Market
6.1 Oral
6.2 Injectables
6.3 Dermal/Topical
6.4 Inhalers
7 Global Generic Injectables Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Region
7.5 Market Breakup by Therapeutic Area
7.6 Market Breakup by Container
7.7 Market Breakup by Distribution Channel
7.8 Market Forecast
7.9 SWOT Analysis
7.9.1 Overview
7.9.2 Strengths
7.9.3 Weaknesses
7.9.4 Opportunities
7.9.5 Threats
7.10 Value Chain Analysis
7.11 Porter’s Five Forces Analysis
7.11.1 Overview
7.11.2 Bargaining Power of Buyers
7.11.3 Bargaining Power of Suppliers
7.11.4 Degree of Competition
7.11.5 Threat of New Entrants
7.11.6 Threat of Substitutes
 7.12 Key Market Drivers and Success Factors
8 Global Generic Injectables Market: Performance of Key Regions
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Latin America
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market by Therapeutic Area
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Anaesthesia
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Anti-infectives
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Parenteral Nutrition
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Cardiovascular
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market by Container
 10.1 Vials
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Ampoules
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Premix
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Prefilled Syringes
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market by Distribution Channel
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Retail Pharmacy
11.2.1 Market Trends
11.2.2 Market Forecast
12 Global Generic Injectables Market: Competitive Landscape
12.1 Market Structure
12.2 Market Breakup by Key Players
13 Generic Injectables Manufacturing Process
13.1 Product Overview
13.2 Detailed Process Flow (Injectables)
13.3 Various Types of Unit Operations Involved
13.4 Mass Balance and Raw Material Requirements
14 Project Details, Requirements and Costs Involved
14.1 Land Requirements and Expenditures
14.2 Construction Requirements and Expenditures
14.3 Plant Machinery
14.4 Machinery Pictures
14.5 Raw Material Requirements and Expenditures
14.6 Packaging Requirements and Expenditures
14.7 Transportation Requirements and Expenditures
14.8 Utility Requirements and Expenditures
14.9 Manpower Requirements and Expenditures
14.10 Other Capital Investments
15 Loans and Financial Assistance
16 Project Economics

16.1 Capital Cost of the Project
16.2 Techno-Economic Parameters
16.3 Product Pricing and Margins Across Various Levels of the Supply Chain
16.4 Taxation and Depreciation
16.5 Income Projections
16.6 Expenditure Projections
16.7 Financial Analysis
16.8 Profit Analysis
17 Key Player Profiles
 17.1 Hospira (Pfizer)
 17.1.1 Company Overview
 17.1.2 Product Portfolio
 17.1.3 Financials
 17.1.4 SWOT Analysis
 17.2 Fresenius Kabi
 17.2.1 Company Overview
 17.2.2 Product Portfolio
 17.2.3 Financials
 17.2.4 SWOT Analysis
 17.3 Hikma
 17.3.1 Company Overview
 17.3.2 Product Portfolio
 17.3.3 Financials
 17.3.4 SWOT Analysis
 17.4 Sandoz (Novartis)
 17.4.1 Company Overview
 17.4.2 Product Portfolio
 17.4.3 Financials
 17.4.4 SWOT Analysis
 17.5 Sagent
 17.5.1 Company Overview
 17.5.2 Product Portfolio
 17.5.3 Financials
 17.5.4 SWOT Analysis
 17.6 Sanofi
 17.6.1 Company Overview
 17.6.2 Product Portfolio
 17.6.3 Financials
 17.6.4 SWOT Analysis
 17.7 Baxter
 17.7.1 Company Overview
 17.7.2 Product Portfolio
 17.7.3 Financials
 17.7.4 SWOT Analysis

List of Figures

Figure 1: Global: Generic Drug Market: Value Trends (in Billion US$), 2017-2022
Figure 2: Global: Generic Drug Market: Breakup by Region (in %), 2022
Figure 3: Global: Generic Drug Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 4: Global: Generic Drug Delivery Market: Oral (in Million US$), 2017, 2022 & 2028
Figure 5: Global: Generic Drug Delivery Market: Injectables (in Million US$), 2017, 2022 & 2028
Figure 6: Global: Generic Drug Delivery Market: Dermal/Topical (in Million US$), 2017, 2022 & 2028
Figure 7: Global: Generic Drug Delivery Market: Inhalers (in Million US$), 2017, 2022 & 2028
Figure 8: Global: Generic Injectables Market: Value Trends (in Billion US$), 2017-2022
Figure 9: Global: Generic Injectables Market: Breakup by Region (in %), 2022
Figure 10: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2022
Figure 11: Global: Generic Injectables Market: Breakup by Container (in %), 2022
Figure 12: Global: Generic Injectables Market: Breakup by Distribution Channel (in %), 2022
Figure 13: Global: Generic Injectables Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 14: Global: Generic Injectables Industry: SWOT Analysis
Figure 15: Global: Generic Injectables Industry: Value Chain Analysis
Figure 16: Global: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 17: North America: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 18: North America: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 19: Europe: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 20: Europe: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 21: Asia: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 22: Asia: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 23: Latin America: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 24: Latin America: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 25: Middle East and Africa: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 26: Middle East and Africa: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 27: Global: Generic Injectables (Oncology) Market: Value Trends (in Million US$), 2017 & 2022
Figure 28: Global: Generic Injectables (Oncology) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 29: Global: Generic Injectables (Anaesthesia) Market: Value Trends (in Million US$), 2017 & 2022
Figure 30: Global: Generic Injectables (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 31: Global: Generic Injectables (Anti-infectives) Market: Value Trends (in Million US$), 2017 & 2022
Figure 32: Global: Generic Injectables (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 33: Global: Generic Injectables (Parenteral Nutrition) Market: Value Trends (in Million US$), 2017 & 2022
Figure 34: Global: Generic Injectables (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 35: Global: Generic Injectables (Cardiovascular) Market: Value Trends (in Million US$), 2017 & 2022
Figure 36: Global: Generic Injectables (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 37: Global: Generic Injectables (Vials) Market: Value Trends (in Million US$), 2017 & 2022
Figure 38: Global: Generic Injectables (Vials) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 39: Global: Generic Injectables (Ampoules) Market: Value Trends (in Million US$), 2017 & 2022
Figure 40: Global: Generic Injectables (Ampoules) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 41: Global: Generic Injectables (Premix) Market: Value Trends (in Million US$), 2017 & 2022
Figure 42: Global: Generic Injectables (Premix) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 43: Global: Generic Injectables (Prefilled Syringes) Market: Value Trends (in Million US$), 2017 & 2022
Figure 44: Global: Generic Injectables (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 45: Global: Generic Injectables Market: Sales through Hospitals (in Million US$), 2017 & 2022
Figure 46: Global: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2023-2028
Figure 47: Global: Generic Injectables Market: Sales through Retail Pharmacy (in Million US$), 2017 & 2022
Figure 48: Global: Generic Injectables Market Forecast: Sales through Retail Pharmacy (in Million US$), 2023-2028
Figure 49: Generic Injectables Manufacturing Process: Conversion Rate of Feedstocks
Figure 50: Generic Injectables Manufacturing: Detailed Process Flow
Figure 51: Generic Injectables Manufacturing: Production Cost Breakup (in %)
Figure 52: Generic Injectables Industry: Profit Margins at Various Levels of the Supply Chain
Figure 53: Generic Injectables Manufacturing Plant: Proposed Plant Layout
Figure 54: Generic Injectables Manufacturing Plant: Breakup of Capital Costs (in %)

List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2023-2028
Table 3: Global: Generic Drug Market: Revenues of Key Players (in Million US$), 2019
Table 4: Global: Generic Injectables Market: Key Industry Highlights, 2022 and 2028
Table 5: Global: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 7: Global: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2023-2028
Table 8: Global: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 9: Generic Injectables Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 10: Generic Injectables Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 11: Generic Injectables Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 12: Generic Injectables Manufacturing Plant: Raw Material Requirements (Kg/Day) and Expenditures (US$/Kg)
Table 13: Generic Injectables Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 14: Generic Injectables Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 15: Details of Financial Assistance Offered by Financial Institutions
Table 16: Generic Injectables Manufacturing Plant: Capital Costs (in US$)
Table 17: Generic Injectables Manufacturing Plant: Techno-Economic Parameters (in US$)
Table 18: Generic Injectables Manufacturing Plant: Taxation and Depreciation (in US$)
Table 19: Generic Injectables Manufacturing Plant: Income Projections (in US$)
Table 20: Generic Injectables Manufacturing Plant: Expenditure Projections (in US$)
Table 21: Generic Injectables Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 22: Generic Injectables Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 23: Generic Injectables Manufacturing Plant: Profit and Loss Account (in US$)

Read More: https://latesttechnicalreviews.com/

Leave a Comment